Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

NCT05877300 is registered in ClinicalTrials.gov with Harvard Apparatus Regenerative Technology, Inc. as lead sponsor.

NCT NCT05877300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05877300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
Lead sponsor
Harvard Apparatus Regenerative Technology, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
July 13, 2023
Completion date
October 16, 2030
Enrollment
10 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal diseases